GB:0AB6 Stock Latest News
Company AnnouncementsHyloris Secures New China Licensing Pathway for Maxigesic IV3M ago
Company AnnouncementsHyloris Strikes Exclusive Orion Deal for Ready-to-Use Pantoprazole IV in Europe9M ago
Company AnnouncementsHyloris Pharmaceuticals Reports Strong 2024 Results and Strategic Progress1y ago- Company AnnouncementsHyloris Pharmaceuticals Receives Positive IDMC Recommendation for Alenura Trial1y ago
Company AnnouncementsHyloris Pharmaceuticals Expands Pipeline with Ready-To-Use Pantoprazole IV1y ago
Company AnnouncementsHyloris Pharmaceuticals Reports Positive Study Results for Dofetilide IV1y ago
Company AnnouncementsHyloris Partners with Colonis Pharma for UK Launch of Innovative Dental Product1y ago
Company AnnouncementsHyloris Pharmaceuticals Updates on Subscription Rights and Voting Securities1y ago
Company AnnouncementsHyloris Pharmaceuticals Issues New Warrants to Enhance Market Position1y ago
Company AnnouncementsHyloris Pharmaceuticals Announces Warrant Plan Expiry and Share Capital Details1y ago
Company AnnouncementsHyloris Pharmaceuticals’ Positive Study Boosts European Expansion1y ago